Saudi Press

Saudi Arabia and the world
Sunday, Nov 23, 2025

World Health Organisation warns countries not to treat Covid-19 patients with unproven medicine amid scramble for a cure

History of medicine abounds with ‘examples of drugs that worked on paper or in a test tube but were actually harmful’, WHO chief says. Warning comes as cases of the respiratory ailment caused by the coronavirus surge worldwide

The World Health Organisation (WHO) on Friday warned governments against treating infected coronavirus patients with medications not scientifically proven to fight the pathogen.

WHO Director General Tedros Adhanom Ghebreyesus issued the warning as cases of Covid-19, the respiratory ailment caused by the coronavirus that emerged in China late last year, surged worldwide, prompting health authorities to scramble to find treatments.

“We call on all individuals and countries to refrain from using therapeutics that have not been demonstrated to be effective in the treatment of Covid-19,” Tedros said. “The history of medicine is strewn with examples of drugs that worked on paper, or in a test tube, but didn't work in humans, or were actually harmful.”

“During the most recent Ebola epidemic, for example, some medicines that were thought to be effective were found not to be as effective as other medicines, when they were compared during a clinical trial,” he said. “We must follow the evidence. There are no short cuts.”

Tedros did not name any individuals, including US President Donald Trump, who came under criticism for touting chloroquine – a medicine for malaria – as a treatment for Covid-19 patients.

Trump defended his aim to start using the medicine regardless of the WHO warning.

Asked in a White House briefing about whether he would continue pushing chloroquine as a treatment, Trump said: “We have people dying now.”

“If we're going to go into labs and test all of this for a long time, we can test it on people right now who are in serious trouble who would dying,” Trump said. “If it works, we've done a great thing. If it doesn't work, you know, we tried.”

The US leader began pushing for chloroquine as a treatment last week.

In a press briefing on March 19, Trump, referring to the medication, said: “Normally the [US Food and Drug Administration] would take a long time to approve something like that, and it was approved very, very quickly and it's now approved, by prescription.”

Soon after Trump’s comments, the FDA said that chloroquine had not been approved for treating Covid-19 and that more tests were needed to determine its safety and effectiveness.

A day later, US infectious disease expert Dr. Anthony Fauci said evidence that chloroquine worked against Sars-CoV-2, the scientific name for the new coronavirus, was “anecdotal”.

The effort to prove the medication’s efficacy against the contagion, he said, “was not done in a controlled clinical trial, so you really can’t make any definitive statement about it”.

Many US media outlets have reported shortages of chloroquine and hydroxychloroquine, a newer derivative of chloroquine that is also used for malaria, since Covid-19 cases began to surge in the country.

Tedros also warned that “off-label” usage of medication – the prescribing of sanctioned drugs for other, unapproved purposes – to treat Covid-19 potentially threatens the health of many individuals not infected with the new illness.

“We need to ensure that using unproven drugs does not create a shortage of those medicines to treat diseases for which they have proven effective,” the head of the UN agency said in the briefing.

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Saudi Arabia Charts Tech and Nuclear Leap Under Crown Prince’s U.S. Visit
Trump Elevates Saudi Arabia to Major Non-NATO Ally Amid Defense Deal
Trump Elevates Saudi Arabia to Major Non-NATO Ally as MBS Visit Yields Deepened Ties
Iran Appeals to Saudi Arabia to Mediate Restart of U.S. Nuclear Talks
Musk, Barra and Ford Join Trump in Lavish White House Dinner for Saudi Crown Prince
Lawmaker Seeks Declassification of ‘Shocking’ 2019 Call Between Trump and Saudi Crown Prince
US and Saudi Arabia Forge Strategic Defence Pact Featuring F-35 Sale and $1 Trillion Investment Pledge
Saudi Sovereign Wealth Fund Emerges as Key Contender in Warner Bros. Discovery Sale
Trump Secures Sweeping U.S.–Saudi Agreements on Jets, Technology and Massive Investment
Detroit CEOs Join White House Dinner as U.S.–Saudi Auto Deal Accelerates
Netanyahu Secures U.S. Assurance That Israel’s Qualitative Military Edge Will Remain Despite Saudi F-35 Deal
Ronaldo Joins Trump and Saudi Crown Prince’s Gala Amid U.S.–Gulf Tech and Investment Surge
U.S.–Saudi Investment Forum Sees U.S. Corporate Titans and Saudi Royalty Forge Billion-Dollar Ties
Elon Musk’s xAI to Deploy 500-Megawatt Saudi Data Centre with State-backed Partner HUMAIN
U.S. Clears Export of Advanced AI Chips to Saudi Arabia and UAE Amid Strategic Tech Partnership
xAI Selects Saudi Data-Centre as First Customer of Nvidia-Backed Humain Project
A Decade of Innovation Stagnation at Apple: The Cook Era Critique
President Trump Hosts Saudi Crown Prince Mohammed bin Salman in Washington Amid Strategic Deal Talks
Saudi Crown Prince to Press Trump for Direct U.S. Role in Ending Sudan War
Trump Hosts Saudi Crown Prince: Five Key Takeaways from the White House Meeting
Trump Firmly Defends Saudi Crown Prince Over Khashoggi Murder Amid Washington Visit
Trump Backs Saudi Crown Prince Over Khashoggi Killing Amid White House Visit
Trump Publicly Defends Saudi Crown Prince Over Khashoggi Killing During Washington Visit
President Donald Trump Hosts Saudi Crown Prince Mohammed bin Salman at White House to Seal Major Defence and Investment Deals
Saudi Arabia’s Solar Surge Signals Unlikely Shift in Global Oil Powerhouse
Saudi Crown Prince Receives Letter from Iranian President Ahead of U.S. Visit
Saudi Arabia’s Crown Prince Begins Washington Visit to Cement Long-Term U.S. Alliance
Saudi Crown Prince Meets Trump in Washington to Deepen Defence, AI and Nuclear Ties
Saudi Arabia Accelerates Global Mining Strategy to Build a New Economic Pillar
Crown Prince Mohammed bin Salman Arrives in Washington to Reset U.S.–Saudi Strategic Alliance
Saudi-Israeli Normalisation Deal Looms, But Riyadh Insists on Proceeding After Israeli Elections
Saudis Prioritise US Defence Pact and AI Deals, While Israel Normalisation Takes Back Seat
Saudi Crown Prince’s Washington Visit Aims to Advance Defence, AI and Nuclear Cooperation
Saudi Delegation Strengthens EU–MENA Security Cooperation in Lisbon
Saudi Arabia’s Fossil-Fuel Dominance Powers Global Climate Blockade
Trump Organization Engages Saudi Government-Owned Real-Estate Deal Amid White House Visit
Trump Organization Nears Billion-Dollar Saudi Real Estate Deal Amid White House Diplomacy
Israel Presses U.S. to Tie Saudi F-35 Sale to Formal Normalisation
What We Know Now: Donald Trump’s Financial Ties to Saudi Arabia
Saudi Arabia’s Ambitious Defence Wish List for Washington: From AI Drones to Nuclear Umbrella
Analysis Shows China, Saudi Arabia and UAE among Major Recipients of Climate Finance Loans
Why a Full Saudi–Israel Normalisation Deal Eludes Trump’s Reach
Trump Presses Saudi Arabia to Normalise Ties with Israel as MBS Prepares for White House Visit
US-Saudi Summit Set for November 18 Seeks Defence Pact and Israel Normalisation Momentum
Comcast CEO Brian Roberts Visits Saudi Arabia Amid Potential Bid for Warner Bros. Discovery
Cristiano Ronaldo Embraces Saudi Arabia’s 2034 World Cup Vision with Key Role
Saudi Arabia’s Execution Campaign Escalates as Crown Prince Readies U.S. Visit
Trump Unveils Middle East Reset: Syria Re-engaged, Saudi Ties Amplified
Saudi Arabia to Build Future Cities Designed with Tourists in Mind, Says Tourism Minister
Saudi Arabia Advances Regulated Stablecoin Plans with Global Crypto Exchange Support
×